1. Home
  2. NWSA vs UTHR Comparison

NWSA vs UTHR Comparison

Compare NWSA & UTHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NWSA
  • UTHR
  • Stock Information
  • Founded
  • NWSA 2012
  • UTHR 1996
  • Country
  • NWSA United States
  • UTHR United States
  • Employees
  • NWSA N/A
  • UTHR N/A
  • Industry
  • NWSA Newspapers/Magazines
  • UTHR Biotechnology: Pharmaceutical Preparations
  • Sector
  • NWSA Consumer Discretionary
  • UTHR Health Care
  • Exchange
  • NWSA Nasdaq
  • UTHR Nasdaq
  • Market Cap
  • NWSA 17.1B
  • UTHR 13.8B
  • IPO Year
  • NWSA N/A
  • UTHR 1999
  • Fundamental
  • Price
  • NWSA $28.38
  • UTHR $453.07
  • Analyst Decision
  • NWSA Strong Buy
  • UTHR Buy
  • Analyst Count
  • NWSA 7
  • UTHR 15
  • Target Price
  • NWSA $38.28
  • UTHR $459.60
  • AVG Volume (30 Days)
  • NWSA 5.2M
  • UTHR 874.5K
  • Earning Date
  • NWSA 11-06-2025
  • UTHR 10-29-2025
  • Dividend Yield
  • NWSA 0.70%
  • UTHR N/A
  • EPS Growth
  • NWSA 345.01
  • UTHR 17.94
  • EPS
  • NWSA 2.07
  • UTHR 25.63
  • Revenue
  • NWSA $8,452,000,000.00
  • UTHR $3,077,800,000.00
  • Revenue This Year
  • NWSA $4.71
  • UTHR $13.71
  • Revenue Next Year
  • NWSA $3.51
  • UTHR $5.38
  • P/E Ratio
  • NWSA $33.79
  • UTHR $17.68
  • Revenue Growth
  • NWSA 2.42
  • UTHR 17.62
  • 52 Week Low
  • NWSA $23.38
  • UTHR $266.98
  • 52 Week High
  • NWSA $31.61
  • UTHR $455.12
  • Technical
  • Relative Strength Index (RSI)
  • NWSA 37.11
  • UTHR 71.57
  • Support Level
  • NWSA $30.07
  • UTHR $415.00
  • Resistance Level
  • NWSA $31.61
  • UTHR $442.01
  • Average True Range (ATR)
  • NWSA 0.64
  • UTHR 12.96
  • MACD
  • NWSA -0.22
  • UTHR -0.38
  • Stochastic Oscillator
  • NWSA 4.15
  • UTHR 96.49

About NWSA News Corporation

News Corporation is a diversified media conglomerate with large presence in the US, the UK, and Australia. Key mastheads include The Wall Street Journal, Barron's, New York Post, The Times, The Sun, The Australian, Herald Sun, and The Daily Telegraph. Its 61%-owned REA Group is the dominant property listings business in Australia. In addition, it owns Harper Collins, one of the largest book publishers in the world, and has a sizable US digital property advertising business, Move. The 65% interest in Foxtel, the Australian pay-TV and streaming provider, was sold in April 2025. The sale to global sports streaming platform, DAZN, was struck at more than 7 times Foxtel's EBITDA.

About UTHR United Therapeutics Corporation

United Therapeutics Corp specializes in drug development for pulmonary arterial hypertension (PAH), a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. The company markets and sells the following commercial therapies in the United States to treat PAH: Tyvaso DPI (treprostinil) Inhalation Powder, Remodulin Injection, Orenitram (treprostinil) Extended-Release Tablets, Adcirca (tadalafil) Tablets, and Unituxin. In addition, it is developing a pipeline of projects that includes new indications and delivery devices for existing products and new products to treat PAH and other conditions.

Share on Social Networks: